Clonidine Tablet, Extended Release
Product Images NDC 68134-603

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 68134-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Palmetto Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aglabel (Ag Label)

Aglabel (Ag Label)
Label for Clonidine Extended-Release Tablets, 0.17 mg strength, oral tablets in a 30-count package. The label includes dosage information, storage instructions, and child-resistant container details. It is labeled as prescription only and manufactured by Palmetto Pharmaceuticals Inc., Greenville, SC. The label also features a barcode and the NDC 68134-603-30.*
FDA Label Image

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)
Chemical structure diagram of the active ingredient clonidine hydrochloride, showing the molecular arrangement including chlorine atoms and an imidazoline ring.*
FDA Label Image

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)
A line graph depicting mean concentration (pg/mL) on the vertical axis versus time (hours) on the horizontal axis, showing the pharmacokinetic profiles of three groups labeled A, B, and C over a 72-hour period. Concentrations peak between 4 and 12 hours and then decline gradually.*
FDA Label Image

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)
Line graph showing blood pressure (mmHg) over time (hours) for two dosing regimens: 0.6 mg extended-release (ER) and 0.3 mg twice daily immediate-release (BID IR) clonidine tablets. Data lines represent systolic and diastolic pressures at multiple time points up to 24 hours after dosing in a sitting position.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.